RNA-Based Drugs: From RNA Interference to Short Interfering RNAs

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|5|4|361-368

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.5, Iss.4, 2004-08, pp. : 361-368

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging RNA-based Drugs: siRNAs, microRNAs and Derivates

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 3, 2012-09 ,pp. : 217-232

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Gene Silencing by Small Interfering RNA-Based Knock-Down Technology

By  

Current Pharmaceutical Biotechnology, Vol. 5, Iss. 1, 2004-02 ,pp. : 1-7

Bentham Science Publishers

Access to resources Recommend Favorite

RNA-based therapeutic strategies for cancer

By Read Martin L   Stevenson Mark   Farrow Paul J   Barrett Lee B   Seymour Leonard W  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 5, 2003-05 ,pp. : 627-638

Informa Healthcare

Access to resources Recommend Favorite

Developing antisense oligonucleotide and short‐interfering RNA therapeutics – a few considerations

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 5, 2015-09 ,pp. : 323-325

John Wiley & Sons Inc

Access to resources Recommend Favorite

Developing antisense oligonucleotide and short‐interfering RNA therapeutics – a few considerations

By  

Clinical Pharmacology In Drug Development, Vol. 2160-763X, Iss. 5, 2015-09 ,pp. : 323-325

John Wiley & Sons Inc

Access to resources Recommend Favorite